The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions

NCT05218616 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Aviga, capsules 50 mg / Sutent®, capsules 50 mg
DRUG: Sutent®, capsules 50 mg / Aviga, capsules 50 mg

Sponsor

JLLC NatiVita

Collaborators

[object Object]